Ahead of the Curve: Early Interventions for Delaying Type 1 Diabetes : Episode 5

Screening for Autoantibodies in Type 1 Diabetes

January 20, 2025

By Javier Morales, MD, FACP, FACE
David Robertson, MD

Opinion

Video

Panelists discuss how screening for autoantibodies can help identify individuals at risk for type 1 diabetes before symptoms develop, enabling earlier intervention and potentially delaying disease onset.

EP: 1.Assessing the Burden of Type 1 Diabetes

EP: 2.Guidelines for Type 1 Diabetes Screening

EP: 3.Defining the Stages of Type 1 Diabetes

EP: 4.Impact of Delayed Intervention In Stage 2 Type 1 Diabetes

Now Viewing

EP: 5.Screening for Autoantibodies in Type 1 Diabetes

EP: 6.Mechanism of Action of Teplizumab in Delaying Onset and Progression of Type 1

EP: 7.Clinical Trial Data for Teplizumab

EP: 8.Patient Selection for Teplizumab and Infusion Process

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!